Many aesthetic and medical professionals ask whether qure microneedling is FDA approved as a standalone treatment or when combined with exosomes. The short answer depends on the specific product claims and how the procedure is marketed in your region.
This article breaks down regulatory status, clinical evidence, labeling rules, and practical guidance so you can align your practice with current standards and patient expectations.
| Aspect | Regulatory Status | Clinical Evidence | Labeling Considerations |
|---|---|---|---|
| Microneedling devices | FDA cleared for general dermatologic use in many cases | Strong for skin texture and collagen induction | Must avoid disease or condition claims unless specified |
| Quatrexx and similar brands | FDA registered facility, cleared microneedle patterns | Published studies support efficacy | Device claims must match clearance |
| Combination with exosomes | Device cleared; biologic claims may require additional review | Early promising data; more robust trials needed | Check jurisdictional guidance on adjunctive biologics |
| Professional practice standards | Follow labeled indications and facility licensing rules | Use evidence-based protocols and documented consent | Document training, indications, and outcomes |
Understanding FDA Clearance for Microneedling Devices
How Approval Pathways Differ
The FDA regulates microneedling devices through clear pathways, most commonly 510(k) clearance, which demonstrates substantial equivalence to a legally marketed predicate device. Manufacturers submit detailed technical files covering safety, biocompatibility, and performance data. Each cleared device has specific indications, and providers must align clinical use with those parameters to remain compliant and minimize regulatory risk.
Quare Microneedling Product Specifications and Claims
Device Design and Intended Use
Quare systems typically feature standardized needle patterns, adjustable penetration depth, and materials validated for repeated use. Product labeling outlines target indications such as improving the appearance of acne scars, photoaging, and skin texture. Before adoption, verify that the intended use matches your procedural plans and that supporting clinical data align with your patient population.
Clinical Evidence Supporting Microneedling with Exosomes
Mechanism and Emerging Data
When combined with exosomes, microneedling may enhance delivery of growth factors and extracellular vesicles, potentially accelerating re-epithelialization and remodeling. Early studies report improvements in skin elasticity, pigmentation, and texture, but larger, well-controlled trials are still evolving. Until more definitive evidence is available, consider this combination promising yet investigational, and incorporate it into protocols with informed consent and outcome tracking.
Practical Implementation in Practice
Training, Documentation, and Compliance
Successful integration requires verified training for operators, standardized consent forms, and meticulous documentation of device lot numbers, settings, and post-procedure instructions. Align billing and coding with the specific cleared indications for the device, avoid extrapolation to non-cleared uses, and stay updated on guidance from regulatory bodies and professional societies to maintain both safety and compliance.
Key Takeaways for Providers
- Confirm FDA clearance or approval specific to the device model and intended use.
- Match clinical protocols to labeled indications and supported evidence.
- Document training, consent, device settings, and outcomes rigorously.
- Stay current with regulatory changes and professional society guidance.
FAQ
Reader questions
Is qure microneedling FDA approved for acne scarring?
The device itself may hold FDA clearance for improving acne scarring, but claims must match the cleared indication; confirm the specific clearance number and intended use with your regulatory affairs or legal team.
Can I combine exosomes with qure microneedling in the United States?
Device clearance generally covers the mechanical action of microneedling; adding exosomes may involve additional biologic regulations, so review guidance from the FDA and your local jurisdiction and document informed consent accordingly.
What documentation is required for qure microneedling procedures?
Maintain device logs, training records, patient consent forms, pre- and post-procedure photographs, and coding details that precisely reflect the cleared indications and settings used during each treatment session.
How do I verify that my qure system is current with FDA guidance?
Check the FDA Establishment Registration and Device Listing database, review any issued warning letters or recall notices, subscribe to agency updates, and consult your compliance officer or legal counsel for practice-specific questions.